GAUTAM, N.; MISHRA, A. Formulation and Characterization of Repaglinide Chitosan Nanoparticles for the Treatment of Diabetes Mellitus Type II. Current Research in Pharmaceutical Sciences, v. 8, n. 4, p. 270-277, 8 Jan. 2019.